India Remakes Global Innovation
Harvard Business Review
SEPTEMBER 14, 2011
Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. In recent years, Indian firms such as Dr Reddy's have also started globalizing their R&D footprint by moving into Western markets. and the U.K.
9 
Let's personalize your content